We are live on ! Find out more
BFA

BlackRock Fund Advisors Portfolio holdings

AUM $542B
1-Year Est. Return 18.13%
This Fund
S&P 500
This Quarter Est. Return
+0.29%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
10 Year Est. Return
AUM
$417B
AUM Growth
-$1.66B
Cap. Flow
+$1.91B
Cap. Flow %
0.46%
Top 10 Hldgs %
9.45%
Holding
4,011
New
140
Increased
1,618
Reduced
1,966
Closed
139

Sector Composition

Rank Sector Weight
1 Healthcare 15.1%
2 Financials 12.85%
3 Technology 12.68%
4 Industrials 10.63%
5 Consumer Discretionary 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGS icon
2676
Natural Gas Services Group
NGS
$457M
$7.39M ﹤0.01%
323,925
-18,401
-5% -$429K
RIGL icon
2677
Rigel Pharmaceuticals
RIGL
$723M
$7.39M ﹤0.01%
230,225
-7,037
-3% -$269K
TSE
2678
DELISTED
Trinseo
TSE
$7.38M ﹤0.01%
275,119
-15,394
-5% -$394K
NETI
2679
DELISTED
Eneti Inc.
NETI
$7.35M ﹤0.01%
40,445
+10,533
+35% +$2.6M
CMLS
2680
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$7.35M ﹤0.01%
452,610
-7,208
-2% -$134K
ORC
2681
Orchid Island Capital
ORC
$1.31B
$7.33M ﹤0.01%
130,816
+84,705
+184% +$5.76M
OXFD
2682
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$7.31M ﹤0.01%
527,534
+64,508
+14% +$872K
AUD
2683
DELISTED
Audacy, Inc.
AUD
$7.3M ﹤0.01%
639,084
-26,131
-4% -$314K
CSS
2684
DELISTED
CSS Industries, Inc.
CSS
$7.3M ﹤0.01%
241,234
-14,450
-6% -$415K
RXII
2685
DELISTED
GALENA BIOPHARMA INC COM
RXII
$7.29M ﹤0.01%
4,290,336
+210,225
+5% +$357K
ASMB icon
2686
Assembly Biosciences
ASMB
$498M
$7.28M ﹤0.01%
+31,499
New +$6.08M
HBOS
2687
DELISTED
HERITAGE FINANCIAL GROUP
HBOS
$7.26M ﹤0.01%
240,698
+215,566
+858% +$6.05M
OCUL icon
2688
Ocular Therapeutix
OCUL
$1.83B
$7.26M ﹤0.01%
345,336
+183,236
+113% +$4.54M
CACQ
2689
DELISTED
Caesars Acquisition Company
CACQ
$7.26M ﹤0.01%
1,055,438
-64,352
-6% -$458K
EVDY
2690
DELISTED
Everyday Health, Inc.
EVDY
$7.24M ﹤0.01%
566,271
+345,335
+156% +$4.38M
CCF
2691
DELISTED
Chase Corporation
CCF
$7.22M ﹤0.01%
181,638
-4,491
-2% -$181K
KTOS icon
2692
Kratos Defense & Security Solutions
KTOS
$8.23B
$7.22M ﹤0.01%
1,145,563
-85,706
-7% -$509K
DCO icon
2693
Ducommun
DCO
$2.56B
$7.21M ﹤0.01%
280,804
-15,314
-5% -$412K
RXDX
2694
DELISTED
Ignyta, Inc.
RXDX
$7.2M ﹤0.01%
476,882
+437,498
+1,111% +$5.29M
JRVR icon
2695
James River Group Holdings
JRVR
$219M
$7.19M ﹤0.01%
278,054
-20,319
-7% -$487K
BBBY
2696
Bed Bath & Beyond
BBBY
$479M
$7.19M ﹤0.01%
424,497
-9,609
-2% -$163K
RELY
2697
DELISTED
Real Industry, Inc.
RELY
$7.18M ﹤0.01%
+632,538
New +$6.57M
ANGI icon
2698
Angi Inc
ANGI
$247M
$7.16M ﹤0.01%
116,293
+3,778
+3% +$232K
LGIH icon
2699
LGI Homes
LGIH
$1.35B
$7.16M ﹤0.01%
362,182
-31,209
-8% -$561K
HCOM
2700
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
$7.14M ﹤0.01%
273,767
-11,926
-4% -$312K

Similar funds

BlackRock Fund Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, BlackRock Fund Advisors held 4,011 positions worth $417B, down 0.4% from $419B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

BlackRock Fund Advisors's Q2 2015 filing shows 140 new, 1,618 increased, 1,966 reduced and 139 closed positions. Its largest new stake was Jazz Pharmaceuticals: 1,516,810 shares worth $267M. The largest sale was LORILLARD INC COM STK, an estimated $553M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • BlackRock Fund Advisors's largest Q2 2015 buy was Jazz Pharmaceuticals: 1,516,810 shares worth $267M.
  • BlackRock Fund Advisors added most to iShares MSCI Germany ETF in Q2 2015, an estimated $739M increase.
  • BlackRock Fund Advisors's biggest Q2 2015 reduction was Qorvo, cutting an estimated $377M.
  • BlackRock Fund Advisors fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $553M.
  • BlackRock Fund Advisors's ten largest holdings make up 9.5% of its $417B portfolio in Q2 2015.
  • BlackRock Fund Advisors opened 140 new positions and closed 139 in Q2 2015.
  • BlackRock Fund Advisors's portfolio value fell 0.4% quarter-over-quarter to $417B.

Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.